1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This Funding Opportunity Announcement (FOA) seeks to support basic and translational research investigating the role of aging in chronic heart, lung, blood, and sleep disorders.Specifically, this FOA solicits revisions (formerly called competing supplements) to currently funded NHLBI R01 grants that employ nonhuman mammals to study the pathogenesis or possible therapeutic treatments of chronic heart, lung, blood, and sleep disorders.Applications should extend the scientific scope of the funded parent projects to include experiments using age-appropriate animals to address how aging and aging-related processes influence chronic heart, lung, blood, and sleep-related disorders.Revision applications can request funds for:1) the purchase of aged animals or in-house aging of animals; and 2) the costs of additional experiments and personnel required.
Funding Opportunity Number: RFA-HL-15-005. Assistance Listing: 93.233,93.837,93.838,93.839. Funding Instrument: G. Category: HL. Award Amount: Up to $75K per award.
Get alerted about grants like this
Save a search for “National Institutes of Health” or related topics and get emailed when new opportunities appear.
Search similar grants →Based on current listing details, eligibility includes: Eligible applicants: State governments; County governments; City or township governments; Special district governments; Independent school districts; Public and State controlled institutions of higher education; Native American tribal governments (Federally recognized); Public housing authorities / Indian housing authorities; Native American tribal organizations (other than Federally recognized); Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Private institutions of higher education; For-profit organizations other than small businesses; Small businesses; Others (see text field entitled Additional Information on Eligibility for clarification). Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Foreign Institutions Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Up to $75K per award Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is November 3, 2015. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Past winners and funding trends for this program
Purpose. This FOA issued by the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute of Neurological Disorders and Stroke (NINDS) solicits Research Project Grant (R01) applications from institutions/organizations that propose to conduct basic and translational research into the neurobiology of pain in sickle cell disease. Applications that promote multidisciplinary collaboration are strongly encouraged. Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) grant mechanism. Funds Available and Anticipated Number of Awards. NHLBI intends to commit up to $6.0 million (total costs) over four years and NINDS intends to commit up to $1.4 million (total costs) over four years.The NHLBI and NINDS anticipate that they will award up to $1.85 million in FY 2009 to fund four applications in response to this FOA.Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Funding Opportunity Number: RFA-HL-09-008. Assistance Listing: 93.839,93.853. Funding Instrument: G. Category: HL. Award Amount: Up to $300K per award.
Purpose.This Funding Opportunity Announcement (FOA), issued by the National Institute of Mental Health (NIMH), solicits Exploratory/Developmental Phased Innovation (R21/R33) grant applications from institutions or organizations that propose to generate and characterize induced pluripotent stem (iPS) cells from human control and/or patient populations with cognitive, affective, social, sleep and developmental brain disorders. This can, but does not need to, include disorders in which a genetic linkage has already been inferred. Applications that combine expertise in stem cell biology, cortical development and the clinical study or treatment of mental disorders are strongly encouraged. Responsive applications will place an emphasis on appropriate validation of iPS cells and their derivatives, evaluating the hetero/homogeneity of any cell populations to be screened and use of cellular assays relevant to brain function and mental disorders. Studies involving the acquisition of tissue from new subjects should include provisions to archive and distribute non-induced (e.g., primary) cells. Since studies likely require several areas of expertise, applicants are encouraged to include multiple PIs on the application. Funding Opportunity Number: RFA-MH-09-130. Assistance Listing: 93.242. Funding Instrument: G. Category: HL. Award Amount: Up to $200K per award.
Purpose. Under this Funding Opportunity Announcement (FOA), the National Institute on Alcohol Abuse and Alcoholism requests Research Project Grant (R01) applications: 1) to test innovative single and combined pharmacologic therapies for alcohol use disorders in HIV+ populations for the purpose of improving adherence to antiretroviral medications, reducing the rate of viral mutation and toxicity related to alcohol-ARV interactions, and reducing sexual risk-taking; and 2) to assess the potential usefulness of medications for alcohol use disorders in preventing secondary HIV infections in targeted high risk populations of gay men and minority women. Mechanism of Support. This FOA will utilize the R01 grant mechanism and runs in parallel with a FOA of identical scientific scope, RFA-AA-09-008, that solicits applications under the expanded R03 grant mechanism to do initial studies of the safety and feasibility of pharmacotherapies for alcohol use disorders in HIV-infected populations. Funds Available and Anticipated Number of Awards. A total of $3.0 M will be awarded and 4-6 awards are anticipated. Funding Opportunity Number: RFA-AA-09-007. Assistance Listing: 93.273. Funding Instrument: G. Category: HL. Award Amount: $3M total program funding.
Agency Information Collection Activities: Submission to the Office of Management and Budget (OMB) for Review and Approval; Public Comment Request; Standardized Work Plan Form for Use with Applications to the Bureau of Health Workforce Research and Training Grants and Cooperative Agreements, OMB No. 0906-0049-Revision is sponsored by Health and Human Services Department; Health Resources and Services Administration. In compliance with the requirement for opportunity for public comment on proposed data collection projects of the Paperwork Reduction Act of 1995, HRSA announces plans to submit an Information Collection Request (ICR), described below, to OMB. Prior to submitting the ICR to OMB, HRSA seeks comments from the public regarding the burden estimate, below, or any other aspect of the ICR. Action: Notice. Published in the Federal Register on 2026-03-06. Federal Register document number: 2026-04493.
Amendment of Notice of Funds Availability for Native American CDFI Assistance Program; Revised Application Submission Deadline is sponsored by Treasury Department; Community Development Financial Institutions Fund. On January 17, 2025, the Community Development Financial Institutions Fund (CDFI Fund) published in the Federal Register (90 FR 6076) a Notice of Funds Availability (NOFA) inviting Applications for Financial Assistance (FA) or Technical Assistance (TA) awards under the Native American CDFI Assistance Program (NACA Program) Fiscal Year (FY) 2025 Funding Round. On September 25, 2025, the CDFI Fund published amendments to the NOFA in the Federal Register (90 FR 46302). As specified in the NOFA amendments, Applicants that submitted an Application under the NOFA and that advanced to step 4 in the scoring/ evaluation process were given an opportunity to update their Applications by 11:59 p.m. Eastern Time on October 27, 2025. However, the submission deadline was affected by the recent lapse in federal government appropriations. Therefore, the CDFI Fund is issuing this notice to revise the submission deadline from 11:59 p.m. Eastern Time on October 27, 2025, to 11:59 p.m. Eastern Time on April 10, 2026. Applicants that were notified by the CDFI Fund that they may update their previous Applications under the NOFA must submit such information by the revised deadline of 11:59 p.m. Eastern Time on April 10, 2026. Action: Revised submission deadline. Published in the Federal Register on 2026-03-10. Federal Register document number: 2026-04683.